A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response.

A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response.
复制标题

基于紫杉烷-蒽环类药物的新辅助化疗反应中的 MicroRNA 表达特征

DOI:
10.7150/jca.11616
复制
发表时间:
2015
期刊:
影响因子:
3.9
通讯作者:
Fu L
Fu L
中科院分区:
医学3区
文献类型:
--
作者:
Zheng Y;Li S;Boohaker RJ;Liu X;Zhu Y;Zhai L;Li H;Gu F;Fan Y;Lang R;Liu F;Qian X;Xu B;Fu L

文献摘要

参考文献

相似文献

识别乳腺癌新辅助化疗的生物标志物的临床需求尚未得到满足。在这里,使用miRNA TaqMan低密度阵列(TLDA),我们分析了接受紫杉烷-蒽环类药物新辅助化疗患者治疗前针吸肿瘤样本中的miRNA表达谱。尽管在无监督的分层聚类分析中,总的miRNA表达谱不能生成一个明确区分病理完全缓解(pCR)和非pCR类别的树,但我们发现miR-125 b和miR-141的表达升高与非pCR相关。体外实验表明,抑制miR-125 b和miR-141表达降低了细胞对紫杉烷-蒽环类药物治疗的反应。此外,与miR-125 b和miR-141模拟物共转染增加了MCF 7和BT 549细胞对紫杉烷-蒽环类药物诱导的细胞毒性的抗性。途径分析表明,miR-125 b的许多靶蛋白参与凋亡途径和细胞周期控制。总之,我们提供的证据表明,miR-125 b和141表达升高预示着紫杉烷-蒽环类药物为基础的新辅助化疗的临床反应性较差。
There is an unmet clinical need to identify biomarkers for breast cancer neoadjuvant chemotherapy. Here, using miRNA TaqMan Low-Density Arrays (TLDA), we analyzed the miRNA expression profile in pre-treatment needle aspiration tumor samples from patients who received taxane-anthracycline-based neoadjuvant chemotherapy. Although, in an unsupervised hierarchical cluster analysis, the total miRNA expression profile could not generate a tree with clear distinction between pathologic complete response (pCR) and non-pCR classes, we found that elevated expression of miR-125b and miR-141 was associated with non-pCR. In vitro experiments indicated that inhibition of miR-125b and miR-141 expression reduced cellular survival in response to taxane-anthracycline treatment. Furthermore, co-transfection with miR-125b and miR-141 mimics increased resistance of MCF7 and BT549 cells to taxane-anthracycline induced cytotoxicity. Pathway analyses indicated that many of the target proteins of miR-125b are involved in apoptotic pathways and cell cycle control. Together, we provide evidence that elevated miR-125b and 141 expression predicts a poor clinical responsiveness of taxane-anthracycline-based neoadjuvant chemotherapy.
DOI: 10.1038/nature03702
发表时间: 2005-06-09
期刊: NATURE
影响因子: 64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者: Golub, TR
ATM-Snail 通路的激活促进乳腺癌转移。
DOI: 10.1093/jmcb/mjs048
发表时间: 2012-10-01
影响因子: 5.5
作者:
Sun, Mianen;Guo, Xiaojing;Xu, Bo
通讯作者: Xu, Bo
DOI: 10.1016/j.ccr.2014.03.007
发表时间: 2014-04-14
期刊: Cancer cell
影响因子: 50.3
作者:
Zhou W;Fong MY;Min Y;Somlo G;Liu L;Palomares MR;Yu Y;Chow A;O'Connor ST;Chin AR;Yen Y;Wang Y;Marcusson EG;Chu P;Wu J;Wu X;Li AX;Li Z;Gao H;Ren X;Boldin MP;Lin PC;Wang SE
通讯作者: Wang SE
DOI: 10.4161/cc.11.6.19665
发表时间: 2012-03-15
期刊: CELL CYCLE
影响因子: 4.3
作者:
Cufi, Silvia;Vazquez-Martin, Alejandro;Menendez, Javier A.
通讯作者: Menendez, Javier A.
DOI: 10.1038/jhg.2011.1
发表时间: 2011-04-01
影响因子: 3.5
作者:
Imanaka, Yukako;Tsuchiya, Soken;Tsujimoto, Gozoh
通讯作者: Tsujimoto, Gozoh